Joel Charrow

Grants

Grants per year 2011 2013 2014 2050

• 12 Active
• 35 Finished

Grants per year

Search results

• Finished

  Lysosomal Storage Disease Training Program for Genetic Counselors

  Charrow, J. (PD/PI)

  Genzyme Corporation

  7/1/14 → 10/1/18

  Project: Research project

• Lysosomal Storage Disease Training Program for Genetic Counselors

  Charrow, J. (PD/PI)

  Genzyme Corporation

  7/1/14 → 10/1/18

  Project: Research project

• LAL-CL06: A Multicenter, Open-Label Study of Sebelipase Alfa in Patients with Lysosomal Acid Lipase Deficiency

  Alonso, E. M. (PD/PI), Bass, L. M. (PD/PI), Burton, B. K. (PD/PI) & Charrow, J. (PD/PI)

  Synageva BioPharma

  6/13/14 → 2/15/19

  Project: Research project

• HGT-HIT-094: A Controlled, Randomized, Two-arm, Open-label, Assessor-blinded, Multicenter Study of Intrathecal Idursulfase-IT Administered in Conjunction with Elaprase® in Pediatric Patients with Hunter Syndrome and Early Cogni

  Alden, T. D. (PD/PI), Burton, B. K. (PD/PI), Charrow, J. (PD/PI) & Rinaldi, J. A. (PD/PI)

  Shire Human Genetic Therapies, Inc.

  4/21/14 → 10/9/18

  Project: Research project

• Development of Patient Reported Outcomes System for Children and Young Adults with pNF Using Mixed Method Approach

  Charrow, J. (PD/PI) & Listernick, R. H. (Co-Investigator)

  Northwestern University, Johns Hopkins University

  2/1/14 → 1/31/16

  Project: Research project

• Development of Patient Reported Outcomes System for Children and Young Adults with pNF Using Mixed Method Approach

  Charrow, J. (PD/PI) & Listernick, R. H. (Co-Investigator)

  Northwestern University, Johns Hopkins University

  2/1/14 → 1/31/16

  Project: Research project

• 111-202: A Phase 2, Open-label, Sequential Cohort Dose-escalation Study of BMN 111 in Children with Achondroplasia

  Charrow, J. (PD/PI) & Burton, B. K. (Co-Investigator)

  BioMarin Pharmaceutical Inc.

  12/2/13 → 8/29/18

  Project: Research project

• Clinical Genetic & Nutritional Counseling Services for Newborn Screening

  Charrow, J. (PD/PI)

  Illinois Department of Public Health

  7/1/13 → 6/30/20

  Project: Research project

• Clinical Genetic & Nutritional Counseling Services for Newborn Screening

  Charrow, J. (PD/PI)

  Illinois Department of Public Health

  7/1/13 → 6/30/20

  Project: Research project

• Clinical Genetic & Nutritional Counseling Services for Newborn Screening

  Charrow, J. (PD/PI)

  Illinois Department of Public Health

  7/1/13 → 6/30/20

  Project: Research project

• Clinical Genetic & Nutritional Counseling Services for Newborn Screening

  Charrow, J. (PD/PI)

  Illinois Department of Public Health

  7/1/13 → 6/30/20

  Project: Research project

• Clinical Genetic & Nutritional Counseling Services for Newborn Screening

  Charrow, J. (PD/PI)

  Illinois Department of Public Health

  7/1/13 → 6/30/20

  Project: Research project

• Clinical Genetic & Nutritional Counseling Services for Newborn Screening

  Charrow, J. (PD/PI)

  Illinois Department of Public Health

  7/1/13 → 6/30/20

  Project: Research project

• Clinical Genetic & Nutritional Counseling Services for Newborn Screening

  Charrow, J. (PD/PI)

  Illinois Department of Public Health

  7/1/13 → 6/30/20

  Project: Research project

• EAP: A Multicenter, Open-label BMN 110 US Expanded Access Program (BMN 110 US EAP) to Provide BMN 110 to Patients Diagnosed with MPS IVA

  Burton, B. K. (PD/PI) & Charrow, J. (Co-Investigator)

  BioMarin Pharmaceutical Inc.

  5/1/13 → 5/1/14

  Project: Research project

• MGM116041: An Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of Migalastat Hydrochloride Monotherapy in Subjects with Fabry Disease

  Charrow, J. (PD/PI)

  GlaxoSmithKline LLC

  4/29/13 → 4/30/15

  Project: Research project

• Protocol BMN 111-201; A Phase 2, Open-label, Sequential Cohort Dose-escalation Study of BMN 111 in Children with Achondroplasia

  Charrow, J. (PD/PI)

  BioMarin Pharmaceutical Inc.

  3/22/13 → 3/23/15

  Project: Research project

• MOR-006: A Phase 2, Open-label, Multinational Study to Evaluate the Efficacy and Safety of BMN 110 in Patients with Mucopolysaccharidosis IVA (Morquio A Syndrome) Who Have Limited Ambulation

  Burton, B. K. (PD/PI) & Charrow, J. (Co-Investigator)

  BioMarin Pharmaceutical Inc.

  3/15/13 → 3/13/15

  Project: Research project

• Inborn Errors of Metabolism Collaborative: Defining the Natural History of Inborn

  Burton, B. K. (PD/PI) & Charrow, J. (Co-Investigator)

  Michigan Public Health Institute, National Institute of Child Health and Human Development

  3/1/13 → 2/29/16

  Project: Research project

• Inborn Errors of Metabolism Collaborative: Defining the Natural History of Inborn

  Burton, B. K. (PD/PI) & Charrow, J. (Co-Investigator)

  Michigan Public Health Institute, National Institute of Child Health and Human Development

  3/1/13 → 2/29/16

  Project: Research project

• Inborn Errors of Metabolism Collaborative: Defining the Natural History of Inborn

  Burton, B. K. (PD/PI) & Charrow, J. (Co-Investigator)

  Michigan Public Health Institute, National Institute of Child Health and Human Development

  3/1/13 → 2/29/16

  Project: Research project

• Prot# AT1001-011: A Double Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacodynamics of AT1001 in Patients with Fabry Disease and AT1001-Responsive GLA Mutations

  Charrow, J. (PD/PI)

  Ann & Robert H. Lurie Children's Hospital of Chicago, Amicus Therapeutics, Inc.

  4/29/11 → 4/29/14

  Project: Research project